Furthermore, we demonstrated that DAPK3 silencing increased the interaction between PKA and UBE3A, but DAPK3 overexpression disrupted PKA and UBE3A binding in renal cancer cells (Fig. 4j, k). This evidence concerns the gene DAPK3 and renal carcinoma.